Skip to content

Comparing Lignocaine and Ketamine for Pain Relief After Laparoscopic Surgery

Comparison of intravenous lignocaine with ketamine for postoperative analgesia in patients undergoing laparoscopic surgery - nil

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/073004
Enrollment
90
Registered
2024-08-27
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G891- Acute pain, not elsewhere classified

Interventions

Intervention1: Intravenous lignocaine bolus followed by infusion given in patients undergoing laparoscopic surgery: 10 mins prior to induction of anaesthesia IV lignocaine bolus of 1.5 mg /kg followed

Sponsors

SGT Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age: 18-65 years 2. Body mass index (BMI): 18-35 kg.m-2 3. Patients having American Society of Anesthesiologists (ASA) Grade I-II 4. Patients scheduled to undergo laparoscopic surgery

Exclusion criteria

Exclusion criteria: 1. Cardiac conduction abnormalities and congestive heart failure 2. Emergency and trauma 3. Neurological disorders 4. Pregnant and lactating women 5. Patients not able to understand V AS 6. History of substance abuse 7. Contraindications to study drugs: lignocaine, ketamine 8. Chronic pain conditions, neurodegenerative or autoimmune disorders.

Design outcomes

Primary

MeasureTime frame
to asses post op analgesia in patients using VAS scoreTimepoint: to asses post op analgesia in patients at rest and on movement at 1 hour 3 hours 6 hours 9 hours 12 hours 24 hours

Secondary

MeasureTime frame
To asses haemodynamic parameters post operativelyTimepoint: to asses post op haemodynamic parameters in patients at- 1 hour 3 hours 6 hours 9 hours 12 hours 24 hours

Countries

India

Contacts

Public ContactDr Shivam Singla

SGT MEDICAL COLLEGE

Dr_savitasaini@yahoo.co.in9416262343

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026